Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BY-NC 4.0The Journal of International Medical Research

The C-reactive protein–albumin–lymphocyte index as a predictor of new-onset atrial fibrillation after ST-segment elevation myocardial infarction: A retrospective cohort study

  • Mengchao Jin1
  • Siliang Peng1
  • Kun Liu2
  • Jiayu Yin1
  • Feng Li1
  • Yang Zhang3,4
4 affiliations
  1. 1Department of Cardiology, The Second Affiliated Hospital of Soochow University, China
  2. 2Department of Cardiology, The First People's Hospital of Lianyungang, China
  3. 3Department of Critical Care Medicine, The Affiliated Hospital of Xuzhou Medical University, China
  4. 4Department of Critical Care Medicine, Suining County People's Hospital, China
Read full textDOICite

Abstract

Objective: New-onset atrial fibrillation is a common complication following ST-segment elevation myocardial infarction and is associated with poor prognosis. The C-reactive protein–albumin–lymphocyte index, a composite biomarker reflecting inflammation, nutritional status, and immune function, has not been fully evaluated for its predictive value for new-onset atrial fibrillation.

Methods: This single-center retrospective study included 665 consecutive patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention between January 2023 and October 2025. The C-reactive protein–albumin–lymphocyte index was calculated from admission laboratory values. New-onset atrial fibrillation was defined as the first documented episode of atrial fibrillation within 30 days after percutaneous coronary intervention. Multivariable logistic regression, receiver operating characteristic curve analysis, and reclassification metrics were used to assess its predictive performance.

Results: New-onset atrial fibrillation occurred in 56 patients (8.4%). In the multivariable model adjusting for age, heart rate, left atrial diameter, infarct-related artery-right coronary artery, left ventricular ejection fraction, fasting blood glucose, and C-reactive protein–albumin–lymphocyte index, five variables remained independently associated with new-onset atrial fibrillation: left atrial diameter (odds ratio = 1.179), infarct-related artery-right coronary artery (odds ratio = 1.992), left ventricular ejection fraction (odds ratio = 0.933), fasting blood glucose (odds ratio = 1.321), and C-reactive protein–albumin–lymphocyte index (odds ratio = 0.813) (all p < 0.05). Among individual biomarkers, the C-reactive protein–albumin–lymphocyte index demonstrated the highest predictive ability (area under the curve = 0.743; 95% confidence interval: 0.685–0.801). Adding the C-reactive protein–albumin–lymphocyte index to a baseline model comprising age, heart rate, left atrial diameter, infarct-related artery-right coronary artery, left ventricular ejection fraction, and fasting blood glucose significantly improved reclassification (net reclassification improvement = 0.7323; p < 0.001; integrated discrimination improvement = 0.0593; p = 0.005).

Conclusions: In this retrospective single-center cohort, a lower admission C-reactive protein–albumin–lymphocyte index was independently associated with clinically documented 30-day new-onset atrial fibrillation after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and may provide incremental predictive information, whereas external validation is required before clinical application.

Related

  1. Predictive value of combined estimated plasma volume status and neutrophil-to-lymphocyte ratio for cardiovascular mortality in patients with acute myocardial infarction with heart failure
    Caizhi Dai, Xiaomin Chen, Xiuting Chen +1
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  2. Prediction of New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction: A Machine Learning Approach
    Nadejda Chiriliuc, Alexandru Corlateanu, Oleg Arnaut +3
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Association Between Admission Calculated Serum Osmolality and New-Onset Atrial Fibrillation in Patients with Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
    Ali Bagci, Hasan Aydın Baş, Yasemin Türker +1
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Active Helicobacter pylori Infection and Atrial Fibrillation in Patients Hospitalized With Acute Myocardial Infarction
    Mohammed Hashem, Martin O. Sundqvist, Jonatan Wärme +2
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, IncPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Enhancer of Zeste Homolog 2 Inhibition Attenuates Atrial Fibrillation Post-Myocardial Infarction Through Reduced Atrial Fibrosis
    Tian-Peng Wei, Wen-Rui Wang, Xiao-Lu Zhang +6
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{jin2026creactive,
  title = {{The C-reactive protein–albumin–lymphocyte index as a predictor of new-onset atrial fibrillation after ST-segment elevation myocardial infarction: A retrospective cohort study}},
  author = {Mengchao Jin and Siliang Peng and Kun Liu and Jiayu Yin and Feng Li and Yang Zhang},
  journal = {The Journal of International Medical Research},
  year = {2026},
  month = sep,
  doi = {10.1177/03000605261487233},
  url = {https://doi.org/10.1177/03000605261487233},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - The C-reactive protein–albumin–lymphocyte index as a predictor of new-onset atrial fibrillation after ST-segment elevation myocardial infarction: A retrospective cohort study
AU  - Mengchao Jin
AU  - Siliang Peng
AU  - Kun Liu
AU  - Jiayu Yin
AU  - Feng Li
AU  - Yang Zhang
PY  - 2026
DA  - 2026/09/17
JO  - The Journal of International Medical Research
DO  - 10.1177/03000605261487233
UR  - https://doi.org/10.1177/03000605261487233
AB  - Objective: New-onset atrial fibrillation is a common complication following ST-segment elevation myocardial infarction and is associated with poor prognosis. The C-reactive protein–albumin–lymphocyte index, a composite biomarker reflecting inflammation, nutritional status, and immune function, has not been fully evaluated for its predictive value for new-onset atrial fibrillation.  Methods: This single-center retrospective study included 665 consecutive patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention between January 2023 and October 2025. The C-reactive protein–albumin–lymphocyte index was calculated from admission laboratory values. New-onset atrial fibrillation was defined as the first documented episode of atrial fibrillation within 30 days after percutaneous coronary intervention. Multivariable logistic regression, receiver operating characteristic curve analysis, and reclassification metrics were used to assess its predictive performance.  Results: New-onset atrial fibrillation occurred in 56 patients (8.4%). In the multivariable model adjusting for age, heart rate, left atrial diameter, infarct-related artery-right coronary artery, left ventricular ejection fraction, fasting blood glucose, and C-reactive protein–albumin–lymphocyte index, five variables remained independently associated with new-onset atrial fibrillation: left atrial diameter (odds ratio = 1.179), infarct-related artery-right coronary artery (odds ratio = 1.992), left ventricular ejection fraction (odds ratio = 0.933), fasting blood glucose (odds ratio = 1.321), and C-reactive protein–albumin–lymphocyte index (odds ratio = 0.813) (all p < 0.05). Among individual biomarkers, the C-reactive protein–albumin–lymphocyte index demonstrated the highest predictive ability (area under the curve = 0.743; 95% confidence interval: 0.685–0.801). Adding the C-reactive protein–albumin–lymphocyte index to a baseline model comprising age, heart rate, left atrial diameter, infarct-related artery-right coronary artery, left ventricular ejection fraction, and fasting blood glucose significantly improved reclassification (net reclassification improvement = 0.7323; p < 0.001; integrated discrimination improvement = 0.0593; p = 0.005).  Conclusions: In this retrospective single-center cohort, a lower admission C-reactive protein–albumin–lymphocyte index was independently associated with clinically documented 30-day new-onset atrial fibrillation after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and may provide incremental predictive information, whereas external validation is required before clinical application.
SN  - 0300-0605
SN  - 1473-2300
ER  -